Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world
- 1 November 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 17 (17), 2419-2427
- https://doi.org/10.1097/00002030-200311210-00003
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?AIDS, 2003
- Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in ProgressClinical Infectious Diseases, 2002
- Ethical Dilemmas Created by the Criminalization of Status Behaviors: Case Examples from Ethnographic Field Research with Injection Drug UsersHealth Education & Behavior, 2002
- Physician-Patient Relationships, Patient Satisfaction, and Antiretroviral Medication Adherence Among HIV-Infected Adults Attending a Public Health ClinicAIDS Patient Care and STDs, 2002
- Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan AfricaThe Lancet, 2000
- Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study GroupJournal of Epidemiology and Community Health, 1999
- Impact of law enforcement on syringe exchange programs: A look at Oakland and San FranciscoMedical Anthropology, 1997
- Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groupsAIDS, 1997
- Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban CommunityThe New England Journal of Medicine, 1994
- Reaching the Unreached: Targeting Hidden IDU Populations with Clean Needles via Known User GroupsJournal of Psychoactive Drugs, 1992